TY  - GEN
AU  - Tcheng,James E
AU  - Kandzari,David E
AU  - Grines,Cindy L
AU  - Cox,David A
AU  - Effron,Mark B
AU  - Garcia,Eulogio
AU  - Griffin,John J
AU  - Guagliumi,Giulio
AU  - Stuckey,Thomas
AU  - Turco,Mark
AU  - Fahy,Martin
AU  - Lansky,Alexandra J
AU  - Mehran,Roxana
AU  - Stone,Gregg W
TI  - Benefits and risks of abciximab use in primary angioplasty for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial
SN  - 1524-4539
PY  - 2003///0930
KW  - Abciximab
KW  - Adult
KW  - Aged
KW  - Angioplasty, Balloon, Coronary
KW  - Antibodies, Monoclonal
KW  - adverse effects
KW  - Combined Modality Therapy
KW  - Coronary Angiography
KW  - Endpoint Determination
KW  - Female
KW  - Humans
KW  - Immunoglobulin Fab Fragments
KW  - Male
KW  - Middle Aged
KW  - Myocardial Infarction
KW  - diagnosis
KW  - Platelet Aggregation Inhibitors
KW  - Platelet Glycoprotein GPIIb-IIIa Complex
KW  - antagonists & inhibitors
KW  - Stents
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial
UR  - https://doi.org/10.1161/01.CIR.0000087601.45803.86
ER  -